CellWell record HH-461727
Microbiota-targeted interventions in chronic kidney disease: probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and traditional Chinese medicine
Liu-Cheng Li; Wen-Hui Cui; Zhihui Zhang; Jing Song; Yaoyao Xu; Ding-Ge Cai; Yan Guan; Kai-Li Mao
Frontiers in Cellular and Infection Microbiology ยท 2026
In plain language
In a review of gut-microbiota therapies for chronic kidney disease, the most robust kidney-function benefit was in non-dialysis stages 3 to 4, with minimal renal gain in dialysis patients.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-461727
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.